Authors:
Rigamonti, AE
Cavallera, G
Bonomo, S
Deghenghi, R
Locatelli, V
Cella, SG
Muller, EE
Citation: Ae. Rigamonti et al., Growth hormone (GH) rebound rise following somatostatin infusion withdrawal: studies in dogs with the use of GH-releasing hormone and a GH-releasing peptide, EUR J ENDOC, 145(5), 2001, pp. 635-644
Authors:
Rigamonti, AE
Cella, SG
Cavallera, GM
Deghenghi, R
Locatelli, V
Pitsikas, N
Muller, EE
Citation: Ae. Rigamonti et al., Contrasting effects of nitric oxide on food intake and GH secretion stimulated by a GH-releasing peptide, EUR J ENDOC, 144(2), 2001, pp. 155-162
Authors:
Pitsikas, N
Rigamonti, AE
Cella, SG
Locatelli, V
Sala, M
Muller, EE
Citation: N. Pitsikas et al., Effects of molsidomine on scopolamine-induced amnesia and hypermotility inthe rat, EUR J PHARM, 426(3), 2001, pp. 193-200
Citation: Ae. Rigamonti et Ee. Muller, Gamma-hydroxybutyric acid and growth hormone secretion - Studies in rats and dogs, ALCOHOL, 20(3), 2000, pp. 293-304
Authors:
De Gennaro-Colonna, V
Rossoni, G
Cocchi, D
Rigamonti, AE
Berti, F
Muller, EE
Citation: V. De Gennaro-colonna et al., Endocrine, metabolic and cardioprotective effects of hexarelin in obese Zucker rats, J ENDOCR, 166(3), 2000, pp. 529-536
Authors:
Rigamonti, AE
Cella, SG
Marazzi, N
Muller, EE
Citation: Ae. Rigamonti et al., Six-week treatment with hexarelin in young dogs: evaluation of the GH responsiveness to acute hexarelin or GHRH administration, and of the orexigeniceffect of hexarelin, EUR J ENDOC, 141(3), 1999, pp. 313-320
Authors:
Rigamonti, AE
Cella, SG
Marazzi, N
Muller, EE
Citation: Ae. Rigamonti et al., Nitric oxide modulation of the growth hormone-releasing activity of Hexarelin in young and old dogs, METABOLISM, 48(2), 1999, pp. 176-182
Authors:
Cappa, M
Rigamonti, AE
Bizzarri, C
Porzio, O
Civolani, P
Cella, SG
Loche, S
Muller, EE
Citation: M. Cappa et al., Commentary - Somatostatin infusion withdrawal: Studies in normal children and in children with growth hormone deficiency, J CLIN END, 84(12), 1999, pp. 4426-4430